BETA: Please send your feedback!
Guangdong Haid Group
002311-CN:SHE
Agricultural Commodities/Milling
—
MID cap
(—)
—
since start of 2019
—
- 5
- 5
- 5
- —
- 2
- 3
- 5
- 4
- 1
- —
- —
- 5
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Pharmaceuticals: Major
Founded 1999
GlaxoSmithKline Plc is a global healthcare company which engages in developing, manufacturing, and marketing of pharmaceutical products including vaccines, over the counter medicines and health-related consumer products. It operates through the following segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare. The Pharmaceuticals segment researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines segment produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare segment markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, the United Kingdom.
website
Headquarters
Executives
| Name | Title | Gender |
| Hua Xue | Chairman & General Manager | Male |
| Ying Zhuo Xu, MBA | Director & Deputy General Manager | Male |
| Xie Wu Jiang | Founder | Male |
| Zhen Xiong Qi, PhD | Chairman-Supervisory Board | null |
| Qiang Luo | Founder | Male |
| Shao Lin Yang, MBA | Chief Financial Officer | Male |
| Jie Wen Lu | Securities Representative | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint 5
-
Pollution Prevention 5
-
Water Conservation 5
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety 2
-
Employee Ownership, Satisfaction, Benefits & Pay 3
-
Workplace Health and Safety 5
-
Integrity of Corporate Governance 4
-
Ethical Practices 1
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 5
GlaxoSmithKline - Competitors and Related Companies
How GlaxoSmithKline stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.
GlaxoSmithKline
GSK-GB:LON
Pharmaceuticals: Major
—
MEGA cap
$41.19
(0.21%)
0.09%
since start of 2019
17.71
Loading…